EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracorporeal Photopheresis in Pediatric and Adult Patients with Graft-Versus-Host Disease

Alexandra Ionete, Marius Surleac iD, Mihaela Uta, Zsofia Varady, Ana Maria Bica, Cristina Georgiana Jercan iD, Anca Colita iD, Daniel Coriu iD

Journal of Clinical Medicine · 01.09.2024 · 13 (17) · 5192

DOI: 10.3390/jcm13175192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.09.2024. Verfasst von Alexandra Ionete und 7 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Bank, Fundeni Clinical Institute, 022328 Bucharest, Romania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Graft-versus-host disease (GVHD) is a severe complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) resulting from histocompatibility differences between donor and host cells leading to inflammation, tissue damage, and compromised patient outcome. Extracorporeal photopheresis (ECP) is considered as a second-line treatment administered to patients with GVHD who do not respond to corticosteroid treatment or who experience a relapse after an initial response and are therefore classified as steroid refractory (SR). The aim of this study is to evaluate the clinical response rates in both pediatric and adult patients with acute (a) or chronic (c) GVHD and to assess the effectiveness of ECP using the real-world data from a single center.

Methods

We performed a retrospective study on 30 patients, including 11 pediatric and 19 adult patients who were treated with ECP as a second-, third-, or fourth-line therapy for (a) and (c) GVHD, alongside corticosteroids and other immunomodulatory medications. The median time from aGVHD onset to ECP was 11.5 days (range: 3 days–9 months), while for cGVHD, the median time was 90 days (range: 2 days–9 months).

Results

The overall response rate (ORR) in the aGVHD patient population was 60% with a median of 9 procedures (range: 2–20). For cGVHD patients, the ORR was 70% after a median of 23.5 ECP procedures (range: 8–43). Most patients had skin involvement, with ECP achieving an ORR of 81.8% in aGVHD and 77.7% in cGVHD cases.

Conclusions

ECP is a beneficial therapy for patients with (a) and (c) GVHD who have not responded to corticosteroids and other forms of immunosuppressive therapy. Specifically, ECP demonstrated efficacy in improving skin and oral symptoms and permitted reductions in or the elimination of their corticosteroid usage. The study found that extending the duration of ECP treatment was associated with better outcomes, and no detectable complications were observed over a 38-week period.

Schlagwörter

Stichwörter der Autor:innen

ECPGVHDallogeneic hematopoietic stem cell transplantationmethylprednisoloneruxolitinib

Autor:innen und Institutionen

  • Stem Cell Bank, Fundeni Clinical Institute, 022328 Bucharest, Romania.
  • Faculty of General Medicine, University of Medicine and Pharmacy "Carol Davila", 020021 Bucharest, Romania.
  • Department of Molecular Genetics, National Institute for Infectious Diseases "Matei Bals", 021105 Bucharest, Romania.
  • Department of Hematology, Fundeni Clinical Institute, 022328 Bucharest, Romania.
  • Department of Hematology-Bone Marrow Transplant Unit, Fundeni Clinical Institute, 022328 Bucharest, Romania.
  • Pediatrics Clinic, Fundeni Clinical Institute, 022328 Bucharest, Romania.

ORCID-Profile: Marius Surleac, Cristina Georgiana Jercan, Anca Colita, Daniel Coriu

Zitieren

APA

Ionete, A., Surleac, M., Uta, M., Varady, Z., Bica, A. M., Jercan, C. G., Colita, A., & Coriu, D. (2024). Extracorporeal Photopheresis in Pediatric and Adult Patients with Graft-Versus-Host Disease. Journal of Clinical Medicine, 13(17), 5192. https://doi.org/10.3390/jcm13175192

Vancouver

Ionete A, Surleac M, Uta M, Varady Z, Bica AM, Jercan CG, et al. Extracorporeal Photopheresis in Pediatric and Adult Patients with Graft-Versus-Host Disease. Journal of Clinical Medicine. 2024;13(17):5192. doi:10.3390/jcm13175192

BibTeX
@article{Ionete2024,
  author = {Ionete, Alexandra and Surleac, Marius and Uta, Mihaela and Varady, Zsofia and Bica, Ana Maria and Jercan, Cristina Georgiana and Colita, Anca and Coriu, Daniel},
  title = {Extracorporeal Photopheresis in Pediatric and Adult Patients with Graft-Versus-Host Disease},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {17},
  pages = {5192},
  doi = {10.3390/jcm13175192}
}
Kostenlos starten →